GlassScriptPhysician profile
James W Clarke
NPI 1295959724
$1,028.56
in general payments reported to CMS, 2019-2025
11 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $14.38 · 2021: $201 · 2022: $150 · 2023: $119 · 2024: $216 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $509.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accuray Incorporated | $323.99 | 2019-2025 | |
| Pfizer INC. | $277.90 | 2021-2025 | |
| Elekta, INC. | $133.55 | 2021 | |
| Boston Scientific Corporation | $133.38 | 2022-2025 | Spaceoar Vue System - 10ml, Spaceoar System |
| Palette Life Sciences, INC. | $41.01 | 2021-2022 | |
| Abbvie INC. | $27.10 | 2020-2021 | |
| Bioprotect Medical, INC. | $23.64 | 2024 | Bioprotect Balloon Implant System |
| Teleflex LLC | $22.67 | 2025 | Barrigel |
| Novocure INC. | $17.79 | 2025 | Optune Lua (Novottf-200t) |
| Tactile Systems Technology INC | $14.76 | 2023 | Flexitouch Plus, Entre Plus |
| Janssen Biotech, INC. | $12.77 | 2023 | Erleada |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Clarke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.